News
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the third patient in Cohort 4 of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback